Scarica l'app Stockscreener
8.11
6.71%
0.51
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABCL Giù?
Forum
Previsione
Abcellera Biologics Inc Borsa (ABCL) Ultime notizie
Is AbCellera Biologics (ABCL) One of the Best Stocks with Biggest Upside? - Yahoo Finance
ABCL Stock Clocks Best Week Since February On Clinical Data Anticipation, Baker Bros Stake Boost - Stocktwits
ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL) - ChartMill
ABCL Jumps As Jazz Deal Fuels Antibody Pipeline Momentum - StocksToTrade
AbCellera Biologics Stock (ABCL) Opinions on Recent Technical Breakout and Pipeline Progress - Quiver Quantitative
Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week? - Stocktwits
ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains? - MSN
Enterprise value to revenue forward of AbCellera Biologics Inc. – NASDAQ:ABCL - TradingView
Enterprise value to EBIT forward of AbCellera Biologics Inc. – NASDAQ:ABCL - TradingView
AbCellera Biologics(ABCL) Stock Options Chain | Quotes & News - Moomoo
Price to sales forward of AbCellera Biologics Inc. – NASDAQ:ABCL - TradingView
Price to earnings forward of AbCellera Biologics Inc. – NASDAQ:ABCL - TradingView
JonesTrading Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $13 - Moomoo
Abcellera Biologics stock hits 52-week high at 6.79 USD By Investing.com - Investing.com Nigeria
ABCL Stock Pops As Jazz Deal Fuels Oncology Ambitions - StocksToTrade
Abcellera Biologics stock hits 52-week high at 6.79 USD - Investing.com UK
AbCellera Biologics, Inc. Actuals & Estimates (NASDAQ:ABCL) - TradingView
ABCL Forecast — Price Target — Prediction for 2027 - TradingView
Jazz Pharmaceuticals (JAZZ) Expands AbCellera Tie Up As Zepzelca Trial Misses Goal - Yahoo Finance
Jazz Pharmaceuticals and AbCellera Biologics Inc. (ABCL) Announce Collaboration - Insider Monkey
12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On - Insider Monkey
Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year? - MSN
Abcellera Biologics Inc (ABCL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AbCellera Biologics (ABCL) 2026 Bloom Burton & Co. Healthcare Investor Conference summary - Quartr
Abcellera Biologics Inc (ABCL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Abcellera Biologics Inc (ABCL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Abcellera Biologics Inc (ABCL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor Therapies - TradingView
BMO Capital Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $7 - Moomoo
A potential billion-dollar deal looks for new ways to beat back cancer - The Business Journals
Abcellera Biologics Inc (ABCL) Institutional Confidence - TradingKey
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies - BioSpace
ABCL and Jazz Pharmaceuticals Enter Collaboration for T-Cell Eng - GuruFocus
Is ABCELLERA BIOLG (ABCL) Outperforming Other Medical Stocks This Year? - MSN
AbCellera (ABCL) Partners with Jazz Pharmaceuticals for Cancer R - GuruFocus
AbCellera, Jazz Partner on Next-Generation Cancer Antibodies - TipRanks
AbCellera (NASDAQ: ABCL) inks Jazz cancer antibody pact with $56M upfront, big milestones - Stock Titan
Jazz taps Abcellera in potential $4B antibody discovery deal - BioWorld News
Jazz Pharmaceuticals, AbCellera announce oncology deal - grafa.com
Jazz, AbCellera in deal to develop T-cell engaging multispecific antibodies - MSN
Pharma M&A Roundup: Protillion Biosciences Enters Drug Discovery Collaboration with Merck, Jazz Pharmaceuticals and AbCellera Enter Collaboration - Pharmaceutical Executive
Jazz Pharmaceuticals, AbCellera partner on cancer antibodies By Investing.com - Investing.com South Africa
Jazz Pharmaceuticals, AbCellera partner on cancer antibodies - Investing.com UK
Jazz Pharmaceuticals (JAZZ) Partners with AbCellera for $848M An - GuruFocus
Jazz Pharmaceuticals plc And AbCellera Biologics Inc Announces Collaboration To Discover Next-Generation T-Cell Engaging Multispecific Antibodies - marketscreener.com
Jazz Pharmaceuticals, AbCellera Biologics to Collaborate on T-cell Engaging Multispecific Antibodies - marketscreener.com
AbCellera: An AI-Era Antibody Platform Trading For Little More Than Its Cash (NASDAQ:ABCL) - Seeking Alpha
Abcellera Biologics Inc (ABCL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Abcellera Biologics Inc (ABCL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Abcellera Biologics Inc (ABCL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Abcellera Biologics Inc (ABCL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AbCellera Biologics Faces Stock Volatility Amid Strategic Decisions - timothysykes.com
3.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):